Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), developer of CardioDialysisTM, a medical device that enables continuous broad-spectrum clearance of inflammatory and pathogenic ...

Dublin, Feb. 10, 2020 (GLOBE NEWSWIRE) -- The "Apheresis Market by Product [Device (Centrifugation, Membrane Separation) Disposable], Procedure (Donor, Therapeutic), Application (Plasmapheresis, ...

ENGLEWOOD, Colo., Aug. 15, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...

DUBLIN--(BUSINESS WIRE)--The "Apheresis Equipment - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering. The report provides separate comprehensive ...

Apheresis for Leukemia and Pediatric Patients. Emerging Economies With Increasing Investments From Government Bodies and Leading Players. This study involved the extensive use of both primary and ...

The growth of the therapeutic apheresis market is driven by rise in prevalence of chronic and autoimmune diseases, technological advancements in apheresis devices, and favorable government initiatives ...

(MENAFN- EIN Presswire) EINPresswire/ -- The global therapeutic apheresis market is projected to grow from US$3.2 billion in 2026 to US$3.9 billion by 2033, at a CAGR of 2.7%. Therapeutic apheresis ...